000 03458nam a22004335i 4500
999 _c368073
_d368073
_x1
001 368073
003 ES-MaUEC
005 20230102121705.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220214s2022 sz | s |||| 0|eng d
020 _a9783030913113
024 7 _a10.1007/978-3-030-91311-3
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQR188.6
_b2022 EB
245 1 0 _aInteraction of Immune and Cancer Cells
_cedited by Magdalena Klink, Izabela Szulc-Kielbik.
250 _aSecond edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XIV, 350 páginas)
_b22 ilustraciones, 20 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aarchivo de texto
_bPDF
490 0 _aExperientia Supplementum
_x2504-3692
_v113
505 0 _aChapter 1: Cancer immunoediting - elimination, equilibrium and immune escape in solid tumors -- Chapter 2: Tumor - Stroma Interaction and Cancer. - Chapter 3: Tumor-infiltrating lymphocytes and their role in solid tumor progression -- Chapter 4: Tumor-associated macrophages - reasons to be cheerful, reasons to be fearful -- Chapter 5: Polymorphonuclear neutrophils and tumors: friend or foe? -- Chapter 6: Role of NK cells in tumor progression -- Chapter 7: The role of myeloid-derived suppressor cells in tumor growth and metastasis -- Chapter 8: Cancer stem cells - an ever hiding foe -- Chapter 9: Adoptive T-cell immunotherapy - Perfecting self-defenses -- Chapter 10: Monoclonal antibodies to CTLA-4 with focus on ipilimumab.
520 _aNow, it its second edition, this book summarizes the role of immune cells in tumor suppression and progression. It describes in detail why tumor cells can survive and spread in spite of the antitumor response of immune cells. Since immunotherapy is an attractive approach to cancer therapy, this book also provides information on the two main strategies: monoclonal antibodies and adaptive T cell immunotherapy, with a focus on recent human clinical trials. A newly added chapter also focuses on the role of Natural Killer cells in tumor progression. The book provides a state-of-the-art, comprehensive overview of immune cells in cancer and is an indispensable resource for researchers and practitioners working or lecturing in the field of cancer research and immunology.
988 _aSpringer_BiomedLife_2022
650 7 _2embne
_9348509
_aCáncer
_xInmunoterapia
700 1 _aKlink, Magdalena
_eeditor literario
_0(orcid)0000-0002-9870-7391
_1https://orcid.org/0000-0002-9870-7391
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_948636
700 _aSzulc-Kielbik, Izabela
_eeditor literario
_0(orcid)0000-0003-1290-697X
_1https://orcid.org/0000-0003-1290-697X
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9683530
776 0 8 _iPrinted edition:
_z9783030913106
776 0 8 _iPrinted edition:
_z9783030913120
776 0 8 _iPrinted edition:
_z9783030913137
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-91311-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b04/2022
_dz
_ep
_zSI